Literature DB >> 22431494

The science behind percutaneous hemodynamic support: a review and comparison of support strategies.

Daniel Burkhoff1, Srihari S Naidu.   

Abstract

Patients in a variety of cardiovascular disease states may benefit from temporary percutaneous cardiac support, including those in acute decompensated heart failure, fulminant myocarditis, acute myocardial infarction with or without cardiogenic shock and those undergoing high-risk percutaneous coronary intervention. The ideal percutaneous cardiac support device is safe, easy to use and versatile enough to meet the needs of various clinical situations and patient cohorts. In addition, it should provide maximal hemodynamic support and protection against myocardial ischemia. With these goals in mind, the scientific principles that govern hemodynamic effectiveness and myocardial protection as they pertain to acute support devices are reviewed.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22431494     DOI: 10.1002/ccd.24421

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  21 in total

1.  Device therapy: Where next in cardiogenic shock owing to myocardial infarction?

Authors:  Daniel Burkhoff
Journal:  Nat Rev Cardiol       Date:  2015-06-09       Impact factor: 32.419

2.  Speckle-Tracking Echocardiographic Strain Analysis Reliably Estimates Degree of Acute LV Unloading During Mechanical LV Support by Impella.

Authors:  Nadjib Hammoudi; Shin Watanabe; Olympia Bikou; Alexandre Ceccaldi; Kenneth Fish; Kelly P Yamada; Satoshi Miyashita; Guillaume Lebreton; Roger J Hajjar; Kiyotake Ishikawa
Journal:  J Cardiovasc Transl Res       Date:  2018-05-29       Impact factor: 4.132

Review 3.  [Percutaneous mechanical circulatory support: options and importance].

Authors:  T Seidler
Journal:  Internist (Berl)       Date:  2014-11       Impact factor: 0.743

Review 4.  When more is not better-appropriately excluding patients from mechanical circulatory support therapy.

Authors:  Mannu Nayyar; Kevin Michael Donovan; Rami N Khouzam
Journal:  Ann Transl Med       Date:  2018-01

Review 5.  'Combat' Approach to Cardiogenic Shock.

Authors:  Alexander G Truesdell; Behnam Tehrani; Ramesh Singh; Shashank Desai; Patricia Saulino; Scott Barnett; Stephen Lavanier; Charles Murphy
Journal:  Interv Cardiol       Date:  2018-05

Review 6.  Myocardial ischemia and coronary disease in heart failure.

Authors:  Beniamino R Pagliaro; Francesco Cannata; Giulio G Stefanini; Leonardo Bolognese
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

7.  Comparative Hemodynamic Effects of Contemporary Percutaneous Mechanical Circulatory Support Devices in a Porcine Model of Acute Myocardial Infarction.

Authors:  Brian R Weil; Filip Konecny; Gen Suzuki; Vijay Iyer; John M Canty
Journal:  JACC Cardiovasc Interv       Date:  2016-10-26       Impact factor: 11.195

Review 8.  Mechanical Circulatory Support for Acute Heart Failure Complicated by Cardiogenic Shock.

Authors:  Min Suk Choi; Hunbo Shim; Yang Hyun Cho
Journal:  Int J Heart Fail       Date:  2020-01-22

9.  Percutaneous Hemodynamic Support in PCI.

Authors:  Jason Hatch; Dmitri Baklanov
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-04

Review 10.  Hemodynamic Support Devices for Shock and High-Risk PCI: When and Which One.

Authors:  George W Vetrovec
Journal:  Curr Cardiol Rep       Date:  2017-08-31       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.